Boston Scientific Corporation (BSX.F) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
The valuation and earnings metrics provided (PE of 18.62 and EPS of 2.09) suggest Boston Scientific remains solidly profitable at current prices, with a multiple that is not excessively high for a medical device company. However, without detailed revenue and margin trends, it is difficult to confirm whether earnings growth is accelerating or slowing. On balance, the data points to a fundamentally profitable business but does not clearly indicate strong near‑term upside or downside based solely on fundamentals.
The stock is trading at €38.91, which is dramatically below its 200‑day moving average of €68.48, signaling a strong downtrend and significant negative momentum. A 21.5% decline in the last month indicates heavy selling pressure and likely damaged investor sentiment. Absent evidence of a clear bottoming pattern or oversold reversal signal (e.g., RSI not provided but likely low), the technical setup currently looks bearish.
Alternative data for Boston Scientific is mixed. Digital engagement (web traffic and app downloads) appears robust, while hiring has dropped sharply, which can signal either efficiency measures or caution on growth. Social media presence is large and generally stable to slightly growing across most platforms, suggesting no major reputational shock.
Overall, the setup for Boston Scientific’s stock currently skews bearish, driven primarily by pronounced technical weakness and a sharp recent drawdown. Fundamentals remain profitable and alternative data is mixed but not catastrophically negative, which tempers the view from extremely bearish to more of a valuation reset and sentiment-driven downturn. Until the price action stabilizes and hiring or growth signals improve, the risk/reward appears tilted to caution in the near term.
You don't hold BSX.F in your mock portfolio yet.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started